| Title: | Predicting Pancreatic Cancer in New-Onset Diabetes Cohort Using a Novel Model With Integrated Clinical and Genetic Indicators: A Large-Scale Prospective Cohort Study |
| Journal: | Cancer Medicine |
| Published: | 11 Nov 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39526476/ |
| DOI: | https://doi.org/10.1002/cam4.70388 |
Publication 14156
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
INTRODUCTION: Individuals who develop new-onset diabetes have been identified as a high-risk cohort for pancreatic cancer (PC), exhibiting an incidence rate nearly 8 times higher than the general population. Hence, the targeted screening of this specific cohort presents a promising opportunity for early pancreatic cancer detection. We aimed to develop and validate a novel model capable of identifying high-risk individuals among those with new-onset diabetes.</p>
METHODS: Employing the UK Biobank cohort, we focused on those developing new-onset diabetes during follow-up. Genetic and clinical characteristics available at registration were considered as candidate predictors. We conducted univariate regression analysis to identify potential indicators and used a 5-fold cross-validation method to select optimal predictors for model development. Five machine learning algorithms were used for model development.</p>
RESULTS: Among 12,735 patients with new-onset diabetes, 100 (0.8%) were diagnosed with PC within 2 years. The final model (area under the curve, 0.897; 95% confidence interval, 0.865-0.929) included 5 clinical predictors and 24 single nucleotide polymorphisms. Two threshold cut-offs were established: 1.28% and 5.26%. The recommended 1.28% cut-off, based on model performance, reduces definitive testing to 13% of the total population while capturing 76% of PC cases. The high-risk threshold is 5.26%. Utilizing this threshold, only 2% of the population needs definitive testing, capturing nearly half of PC cases.</p>
CONCLUSIONS: We, for the first time, combined clinical and genetic data to develop and validate a model to determine the risk of pancreatic cancer in patients with new-onset diabetes using machine learning algorithms. By reducing the number of unnecessary tests while ensuring that a substantial proportion of high-risk patients are identified, this tool has the potential to improve patient outcomes and optimize healthcare sources.</p>
15 Keywords
- Adult
- Aged
- Diabetes Mellitus
- Early Detection of Cancer
- Female
- Humans
- Machine Learning
- Male
- Middle Aged
- Pancreatic Neoplasms
- Polymorphism, Single Nucleotide
- Prospective Studies
- Risk Assessment
- Risk Factors
- United Kingdom
14 Authors
- Yongji Sun
- Chaowen Hu
- Sien Hu
- Hongxia Xu
- Jiali Gong
- Yixuan Wu
- Yiqun Fan
- Changming Lv
- Tianyu Song
- Jianyao Lou
- Kai Zhang
- Jian Wu
- Xiawei Li
- Yulian Wu
1 Application
| Application ID | Title |
|---|---|
| 91799 | Combining genetic, environmental and clinical information to predict the risk of gastrointestinal cancer |
Enabling scientific discoveries that improve human health